News | June 10, 2010

Software Certified for ACC ICD Registry

June 10, 2010 – The American College of Cardiology (ACC) has certified Lumedx Corp. as an official ACC-National Cardiovascular Data Registry (NCDR) Implantable Cardioverter Defibrillator (ICD) Registry 2.0 software vendor.

Lumedx exports to the ICD registry is the latest in a suite of software applications developed to address the growing need for accessible cardiovascular data, streamlined clinical workflows and data management.

As the health care industry places more emphasis on quality measurement, transparency and evidence-based care, registry participation becomes increasingly critical. The ACC-NCDR ICD Registry collects data for implantable cardioverter defibrillator procedures. Version 2.0 has been extended to include pediatric ICD implant data, trial, ventricular, defibrillator, and left-heart lead information at time of implant, revision, replacement or surgical abandonment, and updated quality indicators.

The ICD registry module enables comprehensive data collection while simplifying the registry-participation process. The software is designed to integrate with other Apollo clinical data repository modules so it merges seamlessly with the Lumedx electrophysiology module.

For more information: www.lumedx.com/registry/index.as

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Healthcare cybersecurity concerns have increased dramatically as EMRs and medical devices become more digitally connected.

Healthcare cybersecurity concerns have increased dramatically as EMRs and medical devices become more digitally connected.

Feature | Cybersecurity| August 18, 2017 | Dave Fornell
August 17, 2017 — Cybersecurity has become a growing concern in healthcare as patient data, medical systems and impla
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Overlay Init